Skip to content
Governance Register

← US public companies

Hepion Pharmaceuticals, Inc.

SEC CIK 1583771 · HEPA · last insider filing 2026-05-26

Directors (from insider filings)

NameCapacity as filedFilings
Lopriore Chase Director filed 2026 - 2026
Stetz Gary S. Director · Interim CEO filed 2026 - 2026
Lopriore Vincent S Director · Executive Chairman filed 2026 - 2026
Purcell Michael J. Director filed 2024 - 2026
Appajosyula Sireesh Director filed 2026 - 2026
Jacob Gary S Director · CEO and President filed 2013 - 2024
Brancaccio John P Director · Chairman filed 2013 - 2024
Block Timothy M. Director filed 2013 - 2024
Lbiati Kaouthar Director filed 2022 - 2024
Wijngaard Peter Director filed 2020 - 2023
Foster Robert T Director · Chief Scientific Officer filed 2016 - 2023
Reddi Anand Director filed 2022 - 2022
Adams Thomas PHD Director filed 2016 - 2021
Lippa Arnold Director filed 2015 - 2021
Sapirstein James Director · Chief Executive Officer filed 2014 - 2018
Howson Tamar D Director filed 2016 - 2017
Mcguigan Christopher Director filed 2013 - 2014
Denoyer Bernard Director · Chief Financial Officer filed 2013 - 2014

Officers (from insider filings)

NameTitle as filedFilings
Cavan John T Chief Financial Officer filed 2016 - 2021
Sullivan-Bolyai John Z Chief Medical Officer filed 2016 - 2017
Hornung William Karl Chief Financial Officer filed 2014 - 2015

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.